Provectus Biopharmaceuticals Inc (PVCT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Provectus Biopharmaceuticals Inc (PVCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011540
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals Inc is a biotechnology company that develops pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for recurrent melanoma, PV-10 for metastatic liver cancer and PV-10 for recurrent breast cancer. It offers PH-10 for psoriasis and PH-10 for atopic dermatitis. Provectus conducts research on ongoing clinical trials for indications including breast cancers, melanoma, basal cell carcinoma and squamous cell carcinoma. The company also offers programs and experimental therapeutic in hospitals and institutes in Bethlehem, Houston, Louisville, San Diego, Sydney, Brisbane and Adelaide, among others. Provectus is headquartered in Knoxville, Tennessee, the US.

Provectus Biopharmaceuticals Inc (PVCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Provectus Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 10
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 11
Provectus Pharma And Its Subsidiaries Complete Private Placement Of Units For US$2.5 Million 12
Provectus Pharma Files Registration Statement For A Public Offering For US$50 Million 13
Provectus Pharma Completes Registered Direct Offering Of US$5.1 Million 14
Provectus Biopharmaceuticals Inc – Key Competitors 16
Provectus Biopharmaceuticals Inc – Key Employees 17
Provectus Biopharmaceuticals Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 10, 2016: Provectus Biopharmaceuticals Reports Third Quarter 2016 Financial Results 19
Aug 09, 2016: Provectus Biopharmaceuticals Reports Second Quarter 2016 Financial Results 20
May 10, 2016: Provectus Biopharmaceuticals Reports First Quarter 2016 Financial Results 21
Mar 30, 2016: Provectus Biopharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results 22
Corporate Communications 23
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 23
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 24
Dec 28, 2016: Provectus Biopharmaceuticals Terminates Peter Culpepper as Interim CEO and COO 25
Feb 29, 2016: Provectus Biopharmaceuticals Announces Leadership Changes 26
Legal and Regulatory 27
Nov 30, 2016: Provectus Biopharmaceuticals Announces Notification of NYSE MKT Listing Deficiency 27
Mar 16, 2016: Provectus Announces Results of Internal Investigation 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Provectus Biopharmaceuticals Inc, Medical Equipment, Key Facts, 2016 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Provectus Biopharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 10
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 11
Provectus Pharma And Its Subsidiaries Complete Private Placement Of Units For US$2.5 Million 12
Provectus Pharma Files Registration Statement For A Public Offering For US$50 Million 13
Provectus Pharma Completes Registered Direct Offering Of US$5.1 Million 14
Provectus Biopharmaceuticals Inc, Key Competitors 16
Provectus Biopharmaceuticals Inc, Key Employees 17
Provectus Biopharmaceuticals Inc, Subsidiaries 18

★海外企業調査レポート[Provectus Biopharmaceuticals Inc (PVCT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A. Menarini Industrie Farmaceutiche Riunite Srl-製薬・医療分野:企業M&A・提携分析
    Summary A. Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company that undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio is focused on a …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • European Institute of Oncology-製薬・医療分野:企業M&A・提携分析
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • Haoma Mining NL:企業の戦略・SWOT・財務情報
    Haoma Mining NL - Strategy, SWOT and Corporate Finance Report Summary Haoma Mining NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • H.B. Fuller Company:企業の戦略・SWOT・財務情報
    H.B. Fuller Company - Strategy, SWOT and Corporate Finance Report Summary H.B. Fuller Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Glen Dimplex Group:企業の戦略的SWOT分析
    Glen Dimplex Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Showa Denko Materials Co Ltd:企業の戦略的SWOT分析
    Showa Denko Materials Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Belize Electricity Ltd:企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sareum Holdings Plc (SAR)-製薬・医療分野:企業M&A・提携分析
    Summary Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, SKIL (Sareum Kinase Inhib …
  • Solo Oil plc (SOLO):企業の財務・戦略的SWOT分析
    Summary Solo Oil Plc (Solo Oil), formerly Immersion Technologies International Plc, is an oil and gas exploration and production company that acquires, explores, develops and produces oil and gas resource development and production assets. The company's non operated oil and gas assets portfolio incl …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tampa Electric Co:電力:M&Aディール及び事業提携情報
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • Farmer Bros. Co. (FARM):企業の財務・戦略的SWOT分析
    Farmer Bros. Co. (FARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Arsenal Medical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • Foster Electric Co Ltd:企業の戦略・SWOT・財務情報
    Foster Electric Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foster Electric Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dignity plc (DTY):企業の財務・戦略的SWOT分析
    Dignity plc (DTY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • International Drug Development Institute-製薬・医療分野:企業M&A・提携分析
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Les Laboratoires Servier SAS:企業の戦略的SWOT分析
    Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Arcadis N.V.:企業のM&A・事業提携・投資動向
    Arcadis N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arcadis N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆